Furthermore, we retrieved the corresponding DEGs of HBV-associated HCC from GSE44074 microarray of 17 HBV-associated HCC patients and 71 individuals with non-tumor liver specimens to reveal how the active ingredients of CP act on the HBV-associated HCC. Here, CP is linked to hepatocellular carcinoma.